Strategic partnership RockStep Solutions recently partnered with Microsoft to integrate Azure cloud technologies into its Climb software, signaling a potential for joint go-to-market initiatives, co-selling opportunities, and expanded cloud-enabled capabilities for customers seeking scalable, compliant in vivo data management.

Acquisition signal The reported acquisition by Instem Group in July 2025 indicates a strategic consolidation in the life sciences software space, suggesting potential for cross-sell or product integration conversations, as well as alternative procurement paths and competitive positioning considerations for buyers.

Growth in life sciences Climb targets large multinational pharma, mid-size biotechs, and CROs with in vivo study workflow management, offering a foothold to expand within preclinical research ecosystems, particularly where real-time visibility and data acceleration are procurement priorities.

Funding discipline With a history of NIH SBIR backing and a recent Series A, RockStep demonstrates credible financial backing and validated product-market fit, which can reassure potential customers and investors about continued product evolution and enterprise-grade support.

Cloud-native efficiency The cloud-native design and modern tech stack including Terraform, Azure DevOps, and NetSuite appeal to buyers prioritizing scalable deployment, regulatory compliance, and streamlined operations across vivarium and in vivo data workflows.